Literature DB >> 11087214

Myocardial ischemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X.

A Buffon1, S Rigattieri, S A Santini, V Ramazzotti, F Crea, B Giardina, A Maseri.   

Abstract

The presence of myocardial ischemia in syndrome X (chest pain, "ischemia-like" electrocardiogram changes, and normal coronary angiograms) is uncertain possibly because, when focally distributed, it may not cause contractile dysfunction or lactate production. We measured lipid hydroperoxides (ROOHs) and conjugated dienes (CDs), two sensitive, independent markers of ischemia-reperfusion oxidative stress, in paired aortic and great cardiac vein blood samples before and after pacing-induced tachycardia in nine patients with syndrome X. Diagnostic ischemic S-T segment changes during pacing were followed by a consistent increase in ROOH and CD levels in the great cardiac vein (from 4.83 +/- 1.18 micromol/l at baseline to 7.88 +/- 1.12 micromol/l and from 0.038 +/- 0.002 to 0.051 +/- 0.003 arbitrary units, respectively, P < 0.01). In controls, ROOH and CD levels did not change after pacing. The large postpacing cardiac release of lipid peroxidation products, consistently observed in all patients and similar to that previously observed after ischemia caused by percutaneous transluminal coronary angioplasty, is consistent with an ischemic origin of syndrome X.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087214     DOI: 10.1152/ajpheart.2000.279.6.H2627

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  12 in total

1.  The complex link between brain and heart in cardiac syndrome X.

Authors:  G A Lanza; F Crea
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 2.  Angina pectoris and normal coronary arteries: cardiac syndrome X.

Authors:  Filippo Crea; Gaetano A Lanza
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

Review 3.  Cardiac syndrome X: a critical overview and future perspectives.

Authors:  G A Lanza
Journal:  Heart       Date:  2006-01-06       Impact factor: 5.994

Review 4.  Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms.

Authors:  Richard O Cannon
Journal:  J Am Coll Cardiol       Date:  2009-09-01       Impact factor: 24.094

5.  Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.

Authors:  Carl J Pepine; R David Anderson; Barry L Sharaf; Steven E Reis; Karen M Smith; Eileen M Handberg; B Delia Johnson; George Sopko; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

Review 6.  Microvascular angina: assessment of coronary blood flow, flow reserve, and metabolism.

Authors:  Mark R Vesely; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

Review 7.  Cardiac syndrome X in women: the role of oestrogen deficiency.

Authors:  J C Kaski
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

Review 8.  Cardiac Syndrome X: update 2014.

Authors:  Shilpa Agrawal; Puja K Mehta; C Noel Bairey Merz
Journal:  Cardiol Clin       Date:  2014-06-02       Impact factor: 2.213

Review 9.  Coronary microvascular dysfunction: an update.

Authors:  Filippo Crea; Paolo G Camici; Cathleen Noel Bairey Merz
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983

Review 10.  Fractional flow reserve: physiological basis, advantages and limitations, and potential gender differences.

Authors:  George J Crystal; Lloyd W Klein
Journal:  Curr Cardiol Rev       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.